Prognostic predictors of remission in ocular myasthenia gravis.

Neşe ÇelebisoyAsim OrujovFidan BalayevaHüseyin Nezih ÖzdemirAyşın Kısabay AkFigen Gökçay

Published in: Acta neurologica Belgica (2022)

The presence of AchR Abs (p = 0.034) and an abnormal SFEMG (p = 0.006) at onset as increased risk factors for the presence of ongoing signs necessitating medical treatment.

Keyphrases

myasthenia gravis
healthcare
disease activity
systemic lupus erythematosus
ulcerative colitis
replacement therapy
optical coherence tomography
smoking cessation